Risk estimation from somatic mutation assays.

Abstract excerpt

The ability to quantify somatic mutations in vivo provides a new source of toxicological information that is relevant to the assessment of cancer risk. The major experimental factors that influence the mutant frequency are age, time after treatment, treatment protocol, and tissue analyzed. In untreated mice, the mutant frequency increases very rapidly with age from conception to birth, more slowly from birth to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carcinogens
• Share to Mice
• Share to Mutagenicity Tests